Silicon Valley biotech Integrated Biosciences has raised $17.2 million in seed financing to develop therapeutics for age-related diseases. The funding round included Sutter Hill Ventures, Lifespan Vision Ventures, Root Ventures, Civilization Ventures, Illumina Ventures Labs and additional funding sources. Founded in 2022,…
Helaina has announced a successful $45 million Series B funding round, bringing its total equity funding to $83 million, which will be used to further the development of effera Human Lactoferrin, a protein product designed to support women’s health, active nutrition…
Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, announced positive preliminary results from its Phase IIa clinical trial evaluating ISM001-055, a first-in-class small molecule targeting TNIK (Traf2- and Nck-interacting kinase). ISM001-055 was designed using a unique AI platform to…
The FDA approved the drug amivantamab-vmjw in combination with standard chemotherapy for the treatment of certain adults with non-small cell lung cancer, according to a press release by Johnson & Johnson. The indication applies to adults with locally advanced or metastatic…
Scientists have discovered that the long-term symptoms and impact on health experienced by global populations of COVID-19 patients may be a result of a mutation in SARS-CoV-2, the virus that causes the disease. According to the team, the mutations occur…
A paper recently published by Dr. Ádám Sturm and Dr. Tibor Vellai from Eötvös Loránd University uncovers the critical role of mitochondrial DNA, as well as the different ways in which it can be modified and how these modifications impact…
A groundbreaking study has provided fresh insights into Alzheimer’s disease by analyzing a comprehensive cell atlas of the aged prefrontal cortex from 1.65 million cells sampled from 437 older individuals. Using advanced cellular technology, scientists identified early changes in brain cells…
